Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence (Q35946978)

11 August 2017

Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence (English)

1 reference

11 August 2017

1 reference

7

Karla Kerlikowske

1 reference

11 August 2017

1

Diana S M Buist

1 reference

11 August 2017

9

Diana L Miglioretti

1 reference

11 August 2017

4

Patricia A Carney

1 reference

11 August 2017

6

Tracy Onega

1 reference

11 August 2017

3

Erin J Aiello Bowles

1 reference

11 August 2017

5

Stephen H Taplin

1 reference

11 August 2017

Rod Walker

2

1 reference

PMC publication ID

3348383

11 August 2017

Walter Clinton

series ordinal

8

1 reference

11 August 2017

1 February 2012

1 reference

Cancer Epidemiology, Biomarkers & Prevention

11 August 2017

1 reference

11 August 2017

21

1 reference

11 August 2017

5

1 reference

11 August 2017

720-727

1 reference

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Changes in Invasive Breast Cancer and Ductal Carcinoma In Situ Rates in Relation to the Decline in Hormone Therapy Use

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Recent changes in breast cancer incidence in Spain, 1980-2004.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Screening mammography intervals among postmenopausal hormone therapy users and nonusers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Reported drop in mammography : is this cause for concern?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

The decrease in breast-cancer incidence in 2003 in the United States

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Hormone therapy prescribing patterns in the United States

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Predictive margins with survey data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

A decline in breast-cancer incidence.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Retention of enrollees following a cancer diagnosis within health maintenance organizations in the Cancer Research Network

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Analysis of covariance and standardization as instances of prediction.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348383

Evaluating organized breast cancer screening implementation: the prevention of late-stage disease?

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22301831

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A decline in breast-cancer incidence

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22301831

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22301831

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1055-9965.EPI-11-1115

1 reference

11 August 2017

1 reference

PMC publication ID

3348383

11 August 2017

PubMed publication ID

22301831

1 reference

PMC publication ID

3348383